Privia Health Group, Inc.
PRVAHealthcareNASDAQHealth Information Services · Last scanned Sep 8, 2026
Scan Results
Daily timeframePrivia Health Group, Inc. operates as a national physician-enablement company in the United States. With a market capitalization of $2.64B, it sits in mid-cap territory. The company collaborates with physician practices, health plans, and health systems.
Market Cap
$2.64B
Beta
0.88
P/E (TTM)
93.91
P/E (Fwd)
19.43
EPS (TTM)
$0.22
EPS (Fwd)
$1.06
ROE
4.3%
ROA
2.0%
Cash
$412.2M
Total Debt
$8.7M
Free CF
$95.6M
52W Change
-11.8%
Annual Financials
Cash vs Debt
Where PRVA stands vs its 150-day and 200-day moving averages
As of the September 3, 2026 close, PRVA finished 10.34% below its 150-day moving average ($23.11) and 10.96% below its 200-day moving average ($23.27). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is PRVA overbought or oversold?
At the September 3, 2026 close, PRVA's RSI(14) was 28.1, in oversold territory (below 30). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
With $412.2M in cash and $8.7M in debt, PRVA maintains more liquidity than leverage. This favorable balance sheet position can be an asset when capital markets become less accommodating. Free cash flow comes in at $95.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. Return on equity stands at 4.3%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.36B (2022) to $2.12B (2025), reflecting a 56% increase over the period.
The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. At over 50x earnings, PRVA carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Privia Health Group, Inc. and its sector.